{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:54:42Z","timestamp":1791665682210,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bbi.2019.07.014","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T19:18:08Z","timestamp":1562959088000},"page":"535-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Anti-inflammatory treatment with a soluble epoxide hydrolase inhibitor attenuates seizures and epilepsy-associated depression in the LiCl-pilocarpine post-status epilepticus rat model"],"prefix":"10.1016","volume":"81","author":[{"given":"Yijun","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2019.07.014_b0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.wneu.2017.06.137","article-title":"Tissue expressions of soluble human epoxide hydrolase-2 enzyme in patients with temporal lobe epilepsy","volume":"106","author":"Ahmedov","year":"2017","journal-title":"World Neurosurg."},{"key":"10.1016\/j.bbi.2019.07.014_b0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1152\/physrev.00017.2008","article-title":"Transcription factors in long-term memory and synaptic plasticity","volume":"89","author":"Alberini","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbi.2019.07.014_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/neu.2016.47","article-title":"Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms","volume":"29","author":"Alyu","year":"2017","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.bbi.2019.07.014_b0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.brainres.2009.07.060","article-title":"Characterization of transgenic mice with neuron-specific expression of soluble epoxide hydrolase","volume":"1291","author":"Bianco","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2019.07.014_b0025","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1111\/epi.13457","article-title":"Transient and chronic seizure-induced inflammation in human focal epilepsy","volume":"57","author":"Butler","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbi.2019.07.014_b0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneumeth.2008.04.019","article-title":"The pilocarpine model of temporal lobe epilepsy","volume":"172","author":"Curia","year":"2008","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbi.2019.07.014_b0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbi.2019.07.014_b0040","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tins.2012.11.008","article-title":"Glia and epilepsy: excitability and inflammation","volume":"36","author":"Devinsky","year":"2013","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.bbi.2019.07.014_b0045","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.expneurol.2007.03.008","article-title":"Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat","volume":"205","author":"Goffin","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbi.2019.07.014_b0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.gene.2013.05.008","article-title":"Soluble epoxide hydrolase: gene structure, expression and deletion","volume":"526","author":"Harris","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.bbi.2019.07.014_b0055","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbi.2014.07.016","article-title":"Soluble epoxide hydrolase activity regulates inflammatory responses and seizure generation in two mouse models of temporal lobe epilepsy","volume":"43","author":"Hung","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.07.014_b0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.prostaglandins.2009.06.004","article-title":"Epoxyeicosanoid signaling in CNS function and disease","volume":"91","author":"Iliff","year":"2010","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bbi.2019.07.014_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080922","article-title":"Epoxy fatty acids and inhibition of the soluble epoxide hydrolase selectively modulate GABA mediated neurotransmission to delay onset of seizures","volume":"8","author":"Inceoglu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bbi.2019.07.014_b0070","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.prostaglandins.2017.08.003","article-title":"Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors","volume":"133","author":"Inceoglu","year":"2017","journal-title":"Prostaglandins Other Lipid. Mediat."},{"key":"10.1016\/j.bbi.2019.07.014_b0075","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamaneurol.2016.5042","article-title":"Association of depression and treated depression with epilepsy and seizure outcomes: a multicohort analysis","volume":"74","author":"Josephson","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbi.2019.07.014_b0080","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1007\/s11064-017-2331-8","article-title":"Can neurochemical changes of mood disorders explain the increase risk of epilepsy or its worse seizure control?","volume":"42","author":"Kanner","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbi.2019.07.014_b0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1474-4422(15)00225-2","article-title":"Comorbidities of epilepsy: current concepts and future perspectives","volume":"15","author":"Keezer","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2019.07.014_b0090","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1358\/dot.2009.45.2.1322481","article-title":"Cyclooxygenase in epilepsy: from perception to application","volume":"45","author":"Kulkarni","year":"2009","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.bbi.2019.07.014_b0095","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejps.2012.12.013","article-title":"Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models","volume":"48","author":"Liu","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bbi.2019.07.014_b0100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/rheumatology\/key284","article-title":"Metabolic profiling of human plasma reveals the activation of 5-lipoxygenase in the acute attack of gouty arthritis","volume":"58","author":"Luo","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbi.2019.07.014_b0105","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1073\/pnas.1815746116","article-title":"Inhibition of soluble epoxide hydrolase attenuates a high-fat diet-mediated renal injury by activating PAX2 and AMPK","volume":"116","author":"Luo","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2019.07.014_b0110","first-page":"CD010682","article-title":"Antidepressants for people with epilepsy and depression","volume":"2014","author":"Maguire","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbi.2019.07.014_b0115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2009.11.001","article-title":"Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta","volume":"37","author":"Mazarati","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2019.07.014_b0120","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/brain\/awn117","article-title":"Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine","volume":"131","author":"Mazarati","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2019.07.014_b0125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11940-017-0483-0","article-title":"Epilepsy psychiatric comorbidities: drug selection","volume":"19","author":"Mula","year":"2017","journal-title":"Curr. Treat Options Neurol."},{"key":"10.1016\/j.bbi.2019.07.014_b0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2018.08.020","article-title":"Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy","volume":"837","author":"Paudel","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2019.07.014_b0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.eplepsyres.2015.09.013","article-title":"N-methyl-D-aspartate receptor NR2B subunit involved in depression-like behaviours in lithium chloride-pilocarpine chronic rat epilepsy model","volume":"119","author":"Peng","year":"2016","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.bbi.2019.07.014_b0140","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yebeh.2017.12.038","article-title":"Different behavioral and pathological changes between epilepsy-associated depression and primary depression models","volume":"83","author":"Peng","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.bbi.2019.07.014_b0145","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/0031-9384(93)90351-F","article-title":"Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression","volume":"54","author":"Pucilowski","year":"1993","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbi.2019.07.014_b0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.bbi.2019.07.014_b0155","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jnr.21827","article-title":"Differential subcellular distribution and colocalization of the microsomal and soluble epoxide hydrolases in cultured neonatal rat brain cortical astrocytes","volume":"87","author":"Rawal","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbi.2019.07.014_b0160","doi-asserted-by":"crossref","first-page":"E1944","DOI":"10.1073\/pnas.1601532113","article-title":"Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress","volume":"113","author":"Ren","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2019.07.014_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14728222.2019.1554056","article-title":"The COX-2\/prostanoid signaling cascades in seizure disorders","volume":"23","author":"Rojas","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbi.2019.07.014_b0170","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/jm201468j","article-title":"Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications","volume":"55","author":"Shen","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbi.2019.07.014_b0175","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1474-4422(18)30031-0","article-title":"The roles of surgery and technology in understanding focal epilepsy and its comorbidities","volume":"17","author":"Spencer","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2019.07.014_b0180","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbi.2008.03.009","article-title":"The role of cytokines in the pathophysiology of epilepsy","volume":"22","author":"Vezzani","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.07.014_b0185","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2012.04.004","article-title":"The role of inflammation in epileptogenesis","volume":"69","author":"Vezzani","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2019.07.014_b0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.taap.2014.10.001","article-title":"Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication","volume":"281","author":"Vito","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbi.2019.07.014_b0195","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pharmthera.2017.06.006","article-title":"Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases","volume":"180","author":"Wagner","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbi.2019.07.014_b0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prostaglandins.2018.07.002","article-title":"Neuroprotective effects of epoxyeicosatrienoic acids","volume":"138","author":"Wang","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bbi.2019.07.014_b0205","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.eplepsyres.2017.11.003","article-title":"Asiatic acid and maslinic acid attenuated kainic acid-induced seizure through decreasing hippocampal inflammatory and oxidative stress","volume":"139","author":"Wang","year":"2018","journal-title":"Epilepsy Res."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119301825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119301825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:02:05Z","timestamp":1760169725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159119301825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":41,"alternative-id":["S0889159119301825"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2019.07.014","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory treatment with a soluble epoxide hydrolase inhibitor attenuates seizures and epilepsy-associated depression in the LiCl-pilocarpine post-status epilepticus rat model","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2019.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}